However, an Eli Lilly study that identified chemical impurities in tirzepatide compounded with vitamin B12 shows that these are unapproved drugs with uncertain safety
Providers increasingly encounter patients Read More Protecting Muscle While Treating Obesity: New Protein Targets for Older Adults on GLP-1s Jun 16, 2026 Articles, Diet and Nutrition, Exercise, Geriatric Medicine, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity 1,740 views The rise of highly effective GLP-1 receptor agonists and dual incretin therapies has transformed obesity treatment
However, its typically transient and eases after the body has adapted to the medication or the higher dose youve started
Side effects follow a predictable timeline regardless of which medication you choose
Among 710 patients with type 2 diabetes, there were 17 cases of NAION in patients prescribed semaglutide (the scientific name of both drugs)
The nasal spray format is praised for enabling measured, repeatable dosing, which supports precision in study design